ArticleBlood cancer journal2012

Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo.

T Kiziltepe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.